Apollo Endosurgery to Present at The LD 500 Virtual Conference

LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will present at the LD 500 investor conference on Wednesday, September 2 at 11:40 AM Eastern Time. Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will be presenting to a live virtual audience and available for investor meetings throughout the day.

Investors interested in attending the presentation can register online at https://ld500.ldmicro.com/ to join the group presentation session. A free profile for APEN is available at http://www.ldmicro.com/profile/APEN. Institutional and other qualified investors may request one-on-one meetings via LD Micro if they have an existing relationship, or by contacting APEN’s investor relations, Matt Kreps of Darrow Associates, at mkreps@darrowir.com.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo’s common stock is traded on the Nasdaq Global Market under the symbol “APEN”. For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.

What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.

The upcoming “500” in September is the Company’s most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contacts:

Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com

Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com

SOURCE: Apollo Endosurgery, Inc. via LD Micro

View source version on accesswire.com:
https://www.accesswire.com/603470/Apollo-Endosurgery-to-Present-at-The-LD-500-Virtual-Conference

Staff

Recent Posts

Ascentiz Unveiled Modular Designed Exoskeleton at CES 2026: A Technical Deep Dive into Biomechanical Intelligence

The world's first modular exoskeleton combines quasi-direct-drive hip and cable-drive knee technologies for natural, powerful…

6 hours ago

From Clinical Recovery to Lifelong Empowerment: RoboCT Showcases Integrated Ecosystem Strategy at CES 2026

Leveraging Medical Robotics Heritage, the Company Expands into Consumer Market, Envisioning Exoskeletons as Integral 'New…

6 hours ago

Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs

The consolidated entity will leverage AI and precision engineering to create a comprehensive ecosystem advancing…

6 hours ago

Flo Health’s App Wins Google Play “Best of 2025” Award for Best for Watches in Hong Kong, Taiwan, and Macau

LONDON, Jan. 9, 2026 /PRNewswire/ -- Flo Health, the company behind the globally trusted Flo…

6 hours ago

Gifthealth Celebrates Grand Opening Of New Pharmacy In Mesa

MESA, Ariz., Jan. 9, 2026 /PRNewswire/ -- Gifthealth, a unified digital pharmacy platform, today celebrated the…

6 hours ago

Lucent Health Names Aadam Hussain as Chief Executive Officer Following Brett Rodewald’s Retirement

NASHVILLE, Tenn., Jan. 9, 2026 /PRNewswire/ -- Today, Lucent Health, one of the nation's largest independent…

6 hours ago